Overview of the 2022 WHO classification of thyroid neoplasms

ZW Baloch, SL Asa, JA Barletta, RA Ghossein… - Endocrine …, 2022 - Springer
This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …

2019 European Thyroid Association guidelines for the treatment and follow-up of advanced radioiodine-refractory thyroid cancer

L Fugazzola, R Elisei, D Fuhrer, B Jarzab… - European thyroid …, 2019 - etj.bioscientifica.com
The vast majority of thyroid cancers of follicular origin (TC) have a very favourable outcome,
but 5–10% of cases will develop metastatic disease. Around 60–70% of this subset, hence …

Special types of thyroid carcinoma

ZW Baloch, VA LiVolsi - Histopathology, 2018 - Wiley Online Library
This article reviews the small percentage of thyroid tumours that are not classified as classic
papillary thyroid carcinoma, follicular thyroid carcinoma, and medullary thyroid carcinoma. It …

High grade differentiated follicular cell-derived thyroid carcinoma versus poorly differentiated thyroid carcinoma: a clinicopathologic analysis of 41 cases

LDR Thompson - Endocrine Pathology, 2023 - Springer
Criteria overlap for separating between malignant follicular epithelial cell-derived thyroid
gland neoplasms with high grade features of increased mitoses and tumor necrosis but …

Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells

S Bulotta, R Corradino, M Celano… - Journal of …, 2013 - jme.bioscientifica.com
The diagnosis of conventional and oncocytic poorly differentiated (oPD) thyroid carcinomas
is difficult. The aim of this study is to characterise their largely unknown miRNA expression …

Changes of clinicopathologic characteristics and survival outcomes of anaplastic and poorly differentiated thyroid carcinoma

DY Lee, JK Won, SH Lee, DJ Park, KC Jung, MW Sung… - Thyroid, 2016 - liebertpub.com
Background: This study aimed to analyze the temporal changes of the clinicopathologic
characteristics, and the long-term outcomes, of various types of anaplastic thyroid cancer …

Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT

MS Dettmer, A Schmitt, H Steinert… - Endocrine-related …, 2015 - erc.bioscientifica.com
PDE4 cyclic nucleotide phosphodiesterases regulate cAMP abundance in cells and
therefore regulate numerous processes, including cell growth and differentiation. The rat …

[HTML][HTML] MicroRNA profile of poorly differentiated thyroid carcinomas–new diagnostic and prognostic insights

MS Dettmer, A Perren, H Moch… - Journal of molecular …, 2014 - ncbi.nlm.nih.gov
The diagnosis of conventional and oncocytic poorly differentiated thyroid carcinomas is
difficult. The aim of this study was to characterize their largely unknown miRNA expression …

Genetics, diagnosis, and management of Hürthle cell thyroid neoplasms

DG McFadden, PM Sadow - Frontiers in endocrinology, 2021 - frontiersin.org
Hürthle cell lesions have been a diagnostic conundrum in pathology since they were first
recognized over a century ago. Controversy as to the name of the cell, the origin of the cell …

Poorly differentiated thyroid carcinomas: application of the T urin proposal provides prognostic results similar to those from the assessment of high‐grade features

V Gnemmi, F Renaud, C Do Cao, J Salleron… - …, 2014 - Wiley Online Library
Aims To investigate the performance of two proposed methods for assessing the prognosis
of poorly differentiated thyroid carcinomas (PDTC): the Turin proposal and Hiltzik's …